Aslam Malik

Aslam serves as the Chief Executive Officer of SK pharmteco, a top-tier global CDMO. In this role, he is responsible for driving the company’s strategic direction and increasing the value of the company. Under Aslam’s leadership, SK pharmteco has achieved exponential growth in both small molecules and cell and gene therapies.

Prior to SK pharmteco, Aslam served as the President and CEO of AMPAC Fine Chemicals (AFC), now an SK pharmteco company. Since joining AFC in 1991, Aslam supported various technical and executive leadership positions in Business Development, Research & Development, and others. Dr. Malik also served on the Board of Governors of SOCMA (Society of Chemical Manufactures and Affiliates), the advisory board of Chemical and Engineering News and on the Scientific Advisory Board of Sacramento State University. Aslam has received numerous awards, has authored 21 publications, and holds 56 U.S. and International Patents.

Aslam received his Ph.D. in Organic Chemistry and has over 35 years of experience in the pharmaceutical fine chemicals industry.